98%
921
2 minutes
20
Midfacial hypoplasia is a common condition in clinical practice. It is characteristic of various craniofacial syndromes but can also occur as an isolated form of dento-skeletal dysmorphosis. Managing this condition in growing patients is challenging. Surgical approaches have high relapse rates, whereas orthodontic treatments yield variable results in midface advancement and stability. This study evaluates the effectiveness of the Meazzini-Mazzoleni Enhanced Sutural Protraction (MMESP) protocol for correcting severe midfacial hypoplasia in growing patients. Ten patients, with or without associated malformations, were treated at 2 ERN CRANIO centers: Fondazione IRCCS San Gerardo dei Tintori and ASST Santi Paolo e Carlo-Ospedale San Paolo. Treatment began after assessing circum-maxillary suture maturation. A suture release phase was conducted using either palatal expansion or a modified Alt-RAMEC protocol. A rigid external distractor, anchored skeletally or dentally, was used to advance the midface without osteotomies. After correction, stabilization was achieved with temporary anchorage devices (TADs), intraoral elastics, or a protraction face mask. Lateral cephalograms and craniofacial CT scans at baseline, post-treatment, and 12-month follow-up quantified skeletal changes. Cephalometric superimpositions showed significant, stable midface advancement, averaging 15.68 mm at A point, achieving full correction. 3D CT models confirmed the movement followed the osteotomy trajectory of a Le Fort III procedure, with a cranio-caudal gradient and maximum effect at the maxillary alveolar bone. Tensile deformation with bone apposition was observed along circum-maxillary sutures. The MMESP protocol provides a safe, effective, and stable correction of severe midfacial hypoplasia in growing patients, delivering excellent outcomes.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1097/SCS.0000000000011294 | DOI Listing |
Med Int (Lond)
August 2025
Department of Respiratory and Critical Care Medicine, The First Affiliated Hospital of Chongqing Medical University, Chongqing 400016, P.R. China.
Oropouche virus (OROV) is emerging as a growing public health concern, with increasing numbers of case, an expanding global spread and the potential for severe clinical outcomes. However, despite the increasing incidence, the clinical features of OROV infections have not yet been thoroughly examined. The present systematic review and meta-analysis aimed to investigate the prevalence of clinical manifestations in OROV infections.
View Article and Find Full Text PDFBackground: Anticonvulsants are widely used in treating patients with mental and neurological disorders. Their long-term use increases the risk of a decrease in bone mineral density (BMD) and low-energy fractures. Despite the growing number of studies of drug-induced osteoporosis, the effect of anticonvulsants on bone microarchitecture remains poorly studied.
View Article and Find Full Text PDFEur Heart J Case Rep
September 2025
Cardiovascular Department, Tokushima University Hospital, 7708503 Kuramoto-cho, Tokushima 2-50-1, Japan.
Background: The incidence of cancer therapy-related cardiac dysfunction is increasing with the growing number of breast cancer patients. In particular, patients with active cancer combined with severe irreversible cardiac dysfunction present significant challenges in treatment decision-making.
Case Summary: A 40-year-old woman with Stage II HER-2-positive breast cancer received anthracycline followed by HER2-targeted agents.
MedComm (2020)
September 2025
modulates presynaptic Ca1.3 Ca channel function in inner hair cells (IHCs) and is required for indefatigable synaptic sound encoding. Biallelic variants in are associated with non-syndromic hearing loss (DFNB93).
View Article and Find Full Text PDFFront Allergy
August 2025
Department of Surgery, University of Auckland, Auckland, New Zealand.
Allergic rhinitis (AR) and chronic rhinosinusitis (CRS) are common respiratory conditions that significantly impact patient health and contribute to substantial healthcare burdens. While conventional treatments offer symptom relief, many patients continue to experience persistent symptoms, side effects, or resistance to standard therapies. This highlights the growing need for novel, non-invasive, and sustainable therapeutic strategies to manage chronic airway inflammation.
View Article and Find Full Text PDF